Anti-inflammatory drug candidate protects cognitive function in Alzheimer’s mouse model

Drug Candidate Reduced Inflammation of the Brain and Protected Against Cognitive Deterioration in Alzheimer’s Mouse Model

Summary: 3,6′-dithiopomalidomide (DP), an anti-inflammatory drug candidate, protected mouse models of Alzheimer’s disease against cognitive decline by reducing neuroinflammation.

Source: NIH

An anti-inflammatory drug candidate, known as 3,6′-dithiopomalidomide (DP), designed by researchers at the National Institute on Aging (NIA), protected lab mice against cognitive decline by reducing brain inflammation.


Drug Candidate Reduced Brain Inflammation and Protected Against Cognitive Decline in Alzheimer’s Mouse Model

Leave a Reply

Your email address will not be published. Required fields are marked *